MAGNESIUM OXIDE- magnesium oxide tablet 
Marlex Pharmaceuticals Inc.

----------

MAGNESIUM OXIDE- magnesium oxide tablet

ACTIVE INGREDIENT (In each tablet)

Magnesium Oxide 420 mg

Purpose

Dietary Supplement

Supplement Facts

Serving Size

1 Tablet

Magnesium (as Magnesium Oxide)

Amount per Serving

253mg

% Daily value

63%

Other Ingredients

Colloidal silicon dioxide, Croscarmellose sodium, microcrystalline cellulose, stearic acid

Magnesium oxide may help with magnesium deficiencies.*

SUGGESTED USE

As a dietary supplements, adult take one (1) tablet daily preferably with food or as directed by your healthcare practitioner.

CAUTIONS

If you are pregnant, nursing, taking any medications or have any medical condition, consult your doctor before use. If you have any kidney disease, take only under the supervision of a doctor. Discontinue use and consult your doctor if any adverse reactions occur.

Keep out of reach of children.

Store in a cool, dry place.

DO NOT USE IF IMPRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING.

* These statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Manufactured for/ Distributed by:

Marlex Pharmaceuticals, Inc.,

New Castle, DE 19720

Rev.1 10/23 AA

PRINCIPAL DISPLAY PANEL

NDC 10135-0721-01

Magnesium Oxide 420 mg

100 TABLETS

721-01

MAGNESIUM OXIDE 
magnesium oxide tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:10135-721
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
MAGNESIUM OXIDE (UNII: 3A3U0GI71G) (MAGNESIUM CATION - UNII:T6V3LHY838) MAGNESIUM OXIDE420 mg
Inactive Ingredients
Ingredient NameStrength
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
Product Characteristics
ColorwhiteScoreno score
ShapeROUNDSize11mm
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:10135-721-01100 in 1 BOTTLE; Type 0: Not a Combination Product11/01/2023
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM00111/01/2023
Labeler - Marlex Pharmaceuticals Inc. (782540215)

Revised: 12/2023
Document Id: 0bb5d729-510b-e387-e063-6394a90a1fce
Set id: dc57893c-068a-37d8-e053-2a95a90aa054
Version: 5
Effective Time: 20231204
 
Marlex Pharmaceuticals Inc.